Lilly’s Foundayo receives a positive CHMP opinion for obesity and type 2 diabetes — putting the oral GLP-1 pill on course for EU approval.
News|Articles|September 28, 2026
High Value Freight in a Changing Risk Environment.
Author(s)Tucker Company Worldwide
High-value freight is moving through a more complex risk environment. This whitepaper explores how tighter capacity, rising cargo theft severity, freight fraud, and greater liability scrutiny are reshaping transportation strategy. It also outlines a modern approach to carrier assessment, risk-based controls, and balancing capacity with accountability for shippers of critical, high-consequence freight.
Related to this article
The interleukin-6 receptor inhibitor gains a second indication, though one of two phase 3 trials missed its primary endpoint.
European regulators are increasing pressure on clinical trial sponsors to report study results on time, rolling out new monitoring, reminders and guidance as patient advocates welcome the progress but question whether stronger oversight and enforcement will follow.
Why “we’re safe” is the most dangerous assumption in medical benefit commercialization.
Fox Rothschild's Mark Wagner on why drug shortages are so hard to fix — from the definition gap to API dependency to three-year site approvals.
Incubate’s John Stanford on why MFN hits mid-sized pharma harder — fewer products to absorb margin hits and less access to cheap capital.
AstraZeneca will pay insitro $40 million upfront to apply AI to target discovery in MASH and cardiomyopathies, with no candidates named yet.
AI does not end uncertainty in pharma strategy. Its value depends on how well leaders blend it with experience and evidence while keeping judgment human.
Trending on PharmExec
1
The Bubble You Don’t Know You’re In: A Three-Part Series on The Medical Benefit Bubble
2
FDA Approves Enspryng (Satralizumab) for Thyroid Eye Disease
3
EMA Panel Backs Lilly’s Foundayo for Obesity and Type 2 Diabetes in Europe
4
AstraZeneca Taps insitro AI for MASH in Deal Worth Up to $1.5 Billion
5